Pubblicazioni

Might renin-angiotensin system blockers play a role in the COVID-19 pandemic?

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Battistoni, Allegra; Volpe, Massimo

Response to: Neprilysin inhibitor-angiotensin II receptor blocker combination (sacubitril/valsartan)

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Petramala, L.; Letizia, C.

P2Y12 inhibitors monotherapy after short course of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a meta-analysis of randomized clinical trials including 29 089 patients

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Bianco, Matteo; Careggio, Alessandro; Destefanis, Paola; Luciano, Alessia; Perrelli, Maria Giulia; Quadri, Giorgio; Rossini, Roberta; Campo, Gianluca; Vizzari, Giampiero; D'Ascenzo, Fabrizio; Anselmino, Matteo; Biondi-Zoccai, Giuseppe; Ibáñez, Borja; Montagna, Laura; Varbella, Ferdinando; Cerrato, Enrico

Colchicine significantly increases the risk of non-cardiovascular death in patients with coronary artery disease

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, Mattia; Princi, Giuseppe; Crea, Filippo; Damario, Domenico

Antithrombotic therapy in the early phase of non-ST-elevation acute coronary syndromes: A systematic review and meta-analysis

2020 - EUROPEAN HEART JOURNAL. CARDIOVASCULAR PHARMACOTHERAPY
Galli, M.; Andreotti, F.; D'Amario, D.; Vergallo, R.; Vescovo, G. M.; Giraldi, L.; Migliaro, S.; Ameri, P.; Porto, I.; Crea, F.

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma